In today’s peptide market, third-party Certificates of Analysis (COAs) — often from laboratories such as Janoshik Analytical — are frequently presented as a benchmark of quality and transparency.
At first glance, this appears to be a positive development. However, in practice, the widespread use of such COAs in the reseller segment often creates a false sense of security.
To understand why, it is important to look at how quality verification works in a true B2B environment.
In standard manufacturer-to-buyer relationships, the responsibility for independent testing always lies with the buyer — not the seller. This is a fundamental principle. The purpose of third-party testing is to provide independent verification, free from any potential bias. If the seller commissions and distributes the test themselves, the independence of that verification is inherently compromised.
Manufacturer-side quality-control practices may include:
Product specifications
Internal quality-control procedures
Manufacturer quality control before release, which is not ordinarily issued as a separate document
Independent testing is then conducted by the buyer, if required, as part of their own quality assurance process.
In contrast, the reseller market often relies heavily on pre-generated third-party COAs as a marketing tool. These documents may look highly professional, but they do not establish a verifiable connection to the specific product unit received by the end user.
There is no guaranteed physical linkage between:
The tested sample
The batch being sold
The individual vial delivered to the researcher
This creates a structural limitation: even a valid COA cannot confirm the quality of a specific unit unless strict chain-of-custody controls are in place — which is rarely the case in this segment.
In practice, it is entirely possible to:
Submit a high-quality sample for testing
Obtain a legitimate COA
Continue selling material that does not match the tested sample
This is not a theoretical concern, but a known issue within the market.
As a result, the presence of a third-party COA should not be interpreted as a guarantee of product quality. It is, at best, a limited data point — and in many cases, primarily a marketing asset.
At PeptidesFromChina, we have deliberately chosen not to rely on this model.
Instead, our approach is based on:
Direct sourcing from vetted manufacturers
Communication about applicable product specifications and manufacturer-side quality control
Manufacturer-side sourcing coordination together with international logistics
Clear communication about what is and is not verified
We believe that maintaining integrity in sourcing practices is more important than presenting documents that may create a misleading impression of certainty.
For researchers who require independent verification, the most reliable approach remains the same: testing the material independently after purchase.
Our role is to provide access to trusted manufacturing sources — not to simulate guarantees that cannot be meaningfully enforced.